Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Income from Non-Controlling Interests (2016 - 2025)

Marimed (MRMD) has disclosed Income from Non-Controlling Interests for 10 consecutive years, with $7000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Non-Controlling Interests fell 56.25% to $7000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $41000.0, a 35.94% decrease, with the full-year FY2024 number at $37000.0, up 54.17% from a year prior.
  • Income from Non-Controlling Interests was $7000.0 for Q3 2025 at Marimed, up from -$1000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $110040.0 in Q4 2021 to a low of -$19000.0 in Q1 2023.
  • A 5-year average of $33896.8 and a median of $16000.0 in 2022 define the central range for Income from Non-Controlling Interests.
  • Biggest YoY gain for Income from Non-Controlling Interests was 650.0% in 2023; the steepest drop was 162.5% in 2023.
  • Marimed's Income from Non-Controlling Interests stood at $110040.0 in 2021, then tumbled by 96.36% to $4000.0 in 2022, then skyrocketed by 650.0% to $30000.0 in 2023, then tumbled by 90.0% to $3000.0 in 2024, then soared by 133.33% to $7000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Income from Non-Controlling Interests are $7000.0 (Q3 2025), -$1000.0 (Q2 2025), and $32000.0 (Q1 2025).